The Prevalence of Metabolic Dysfunction-Associated Fatty Liver Disease and Its Association with Physical Function and Prognosis in Patients with Acute Coronary Syndrome

Estimating global prevalence of metabolic dysfunction-associated fatty liver disease in overweight or obese adults

(2021) Jiaye Liu et al.   Clinical Gastroenterology and Hepatology

MAFLD Criteria Guide the Subtyping of Patients with Fatty Liver Disease

(2021) Jiaofeng Huang et al.   Risk Management and Healthcare Policy

Evidence-Based Aerobic Exercise Training in Metabolic-Associated Fatty Liver Disease: Systematic Review with Meta-Analysis

(2021) Joanna Słomko et al.   Journal of Clinical Medicine

Metabolic dysfunction-associated fatty liver disease is associated with increased all-cause mortality in the United States

(2021) Donghee Kim et al.   JOURNAL OF HEPATOLOGY

Non‐alcoholic fatty liver disease and sarcopenia additively increase mortality: a Korean nationwide survey

(2021) Joon Ho Moon et al.   Journal of Cachexia Sarcopenia and Muscle

Association between sarcopenia and atherosclerosis in elderly patients with ischemic heart disease

(2020) Shota Uchida et al.   HEART AND VESSELS

Epidemiological feature of NAFLD from 1999 to 2018 in China

(2020) Jianghua Zhou et al.   HEPATOLOGY

A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement

(2020) Mohammed Eslam et al.   JOURNAL OF HEPATOLOGY

Increasing liver fat is associated with progression of cardiovascular risk factors

(2020) Katherine T. Brunner et al.   LIVER INTERNATIONAL

Improvement in histological endpoints of MAFLD following a 12-week aerobic exercise intervention

(2020) Philip O’Gorman et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

NAFLD and cardiovascular diseases: a clinical review

(2020) Philipp Kasper et al.   Clinical Research in Cardiology

Repeated FIB-4 measurements can help identify individuals at risk of severe liver disease

(2020) Hannes Hagström et al.   JOURNAL OF HEPATOLOGY

Cachexia, muscle wasting, and frailty in cardiovascular disease

(2020) Agata Bielecka‐Dabrowa et al.   EUROPEAN JOURNAL OF HEART FAILURE

The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease

(2020) Mohammed Eslam et al.   Hepatology International

Diabetes and Sarcopenic Obesity: Pathogenesis, Diagnosis, and Treatments

(2020) Mina Wang et al.   Frontiers in Endocrinology

Nonalcoholic Fatty Liver Disease and the Heart

(2019) Eric P. Stahl et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Fatty liver index (FLI) and prediction of new cases of non-alcoholic fatty liver disease: A population-based study of northern Iran

(2019) Nima Motamed et al.   CLINICAL NUTRITION

Prevalence and long-term outcomes of non-alcoholic fatty liver disease among elderly individuals from the United States

(2019) Pegah Golabi et al.   BMC GASTROENTEROLOGY

Sarcopenia and fatty liver disease

(2019) Jung A. Kim et al.   Hepatology International

Characteristic Features of Nonalcoholic Fatty Liver Disease in Japan with a Focus on the Roles of Age, Sex and Body Mass Index

(2019) Maki Tobari et al.   Gut and Liver

Non-alcoholic fatty liver disease, a new and growing risk indicator for cardiovascular disease

(2019) Arne Janssen et al.   European Journal of Preventive Cardiology

Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007–2017

(2018) Thomas R. Einarson et al.   Cardiovascular Diabetology

Frailty in advanced liver disease

(2018) Robyn Laube et al.   LIVER INTERNATIONAL

Validity of Japanese version of SARC-F questionnaire in patients with chronic liver disease

(2018) Satoshi Ida et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Skeletal muscle mass to visceral fat area ratio is an important determinant affecting hepatic conditions of non-alcoholic fatty liver disease

(2017) Takashi Shida et al.   JOURNAL OF GASTROENTEROLOGY

Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017-Part 1: Definition, risk factors and assessment

(2017) Vincent Wai-Sun Wong et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Aerobic vs. resistance exercise in non-alcoholic fatty liver disease: A systematic review

(2017) Ryuki Hashida et al.   JOURNAL OF HEPATOLOGY

Effects of lifestyle interventions on clinical characteristics of patients with non-alcoholic fatty liver disease: A meta-analysis

(2017) Christina N Katsagoni et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Insulin resistance and sarcopenia: mechanistic links between common co-morbidities

(2016) Mark E Cleasby et al.   JOURNAL OF ENDOCRINOLOGY

Non-alcoholic fatty liver disease and cardiovascular risk: Pathophysiological mechanisms and implications

(2016) Sven M. Francque et al.   JOURNAL OF HEPATOLOGY

Developmental origins of NAFLD: a womb with a clue

(2016) Stephanie R. Wesolowski et al.   Nature Reviews Gastroenterology & Hepatology

Quadriceps Strength as a Predictor of Mortality in Coronary Artery Disease

(2015) Kentaro Kamiya et al.   AMERICAN JOURNAL OF MEDICINE

Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease

(2015) Paul Angulo et al.   GASTROENTEROLOGY

Effects of growth hormone–releasing hormone on visceral fat, metabolic, and cardiovascular indices in human studies

(2015) Takara L. Stanley et al.   GROWTH HORMONE & IGF RESEARCH

The Implications of Sarcopenia and Sarcopenic Obesity on Cardiometabolic Disease

(2015) Tae Nyun Kim et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

NAFLD: A multisystem disease

(2015) Christopher D. Byrne et al.   JOURNAL OF HEPATOLOGY

External Validation of Fatty Liver Index for Identifying Ultrasonographic Fatty Liver in a Large-Scale Cross-Sectional Study in Taiwan

(2015) Bi-Ling Yang et al.   PLoS One

Muscle contractile and metabolic dysfunction is a common feature of sarcopenia of aging and chronic diseases: From sarcopenic obesity to cachexia

(2014) Gianni Biolo et al.   CLINICAL NUTRITION

Prevalence and associated metabolic factors of fatty liver disease in the elderly

(2013) Zhongli Wang et al.   EXPERIMENTAL GERONTOLOGY

Frailty Assessment in the Cardiovascular Care of Older Adults

(2013) Jonathan Afilalo et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor?

(2012) Lokpal S. Bhatia et al.   EUROPEAN HEART JOURNAL

A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis

(2012) Pontus Boström et al.   NATURE

2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction

(2011) Jeffrey L. Anderson et al.   CIRCULATION

Sarcopenia With Limited Mobility: An International Consensus

(2011) John E. Morley et al.   Journal of the American Medical Directors Association

Insulin Resistance: the Link Between Obesity and Cardiovascular Disease

(2011) Gerald M. Reaven   MEDICAL CLINICS OF NORTH AMERICA

The roles of obesity and gender on the relationship between metabolic risk factors and non-alcoholic fatty liver disease in Koreans

(2009) Kayoung Lee et al.   DIABETES-METABOLISM RESEARCH AND REVIEWS